Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PROVECTUS BIOPHARMACEUTICALS, INC. | 2,847,849 | reported | 28 May 2026 | tx 192+26,393,702−1,899,845 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 23 May 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 23 May 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | 32,089 | 0.00 USD | deriv |
| 15 May 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 15 May 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | 22,651 | 0.00 USD | deriv |
| 07 May 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 07 May 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | 18,876 | 0.00 USD | deriv |
| 29 Apr 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 29 Apr 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | 30,202 | 0.00 USD | deriv |
| 25 Mar 2026 | GRANT_AWARD | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 20 Mar 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | 49,067 | 0.00 USD | deriv |
| 20 Mar 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 12 Mar 2026 | GRANT_AWARD | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 26 Feb 2026 | GRANT_AWARD | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 20 Feb 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | 47,180 | 0.00 USD | deriv |
| 20 Feb 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 19 Feb 2026 | GRANT_AWARD | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 12 Feb 2026 | GRANT_AWARD | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 09 Feb 2026 | PURCHASE | PROVECTUS BIOPHARMACEUTICALS, INC. | 34,940 | 2.86 USD | derivfirst after silence |
| 05 Feb 2026 | GRANT_AWARD | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 30 Jan 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 30 Jan 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | 37,744 | 0.00 USD | deriv |
| 28 Jan 2026 | GRANT_AWARD | PROVECTUS BIOPHARMACEUTICALS, INC. | — | 0.00 USD | deriv |
| 16 Jan 2026 | EXERCISE | PROVECTUS BIOPHARMACEUTICALS, INC. | 37,744 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 09 Feb 2026.